145 related articles for article (PubMed ID: 30475415)
1. Treating hepatitis C virus in dialysis patients: How, when, and why?
Pagan J; Ladino M; Roth D
Semin Dial; 2019 Mar; 32(2):152-158. PubMed ID: 30475415
[TBL] [Abstract][Full Text] [Related]
2. Therapy of hepatitis C by direct-acting anti-virals: the end of HCV in dialysis population?
Fabrizi F; Messa P
Expert Rev Clin Pharmacol; 2015; 8(6):785-93. PubMed ID: 26365524
[TBL] [Abstract][Full Text] [Related]
3. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
Vallet-Pichard A; Pol S
Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis C infections in dialyzed patients].
Podlasin RB
Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
[TBL] [Abstract][Full Text] [Related]
5. The association of hepatitis C infection with the onset of CKD and progression into ESRD.
Henson JB; Sise ME
Semin Dial; 2019 Mar; 32(2):108-118. PubMed ID: 30496620
[TBL] [Abstract][Full Text] [Related]
6. When and how can nephrologists treat hepatitis C virus infection in dialysis patients?
Davis MI; Chute DF; Chung RT; Sise ME
Semin Dial; 2018 Jan; 31(1):26-36. PubMed ID: 28925068
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of HCV infection in patients with advanced CKD/ESRD: A global perspective.
Fabrizi F; Messa P
Semin Dial; 2019 Mar; 32(2):93-98. PubMed ID: 30536715
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis.
He YL; Yang SJ; Hu CH; Dong J; Gao H; Yan TT; Liu JF; Yang Y; Ren DF; Zhu L; Zhao YR; Chen TY
Aliment Pharmacol Ther; 2018 Feb; 47(4):526-532. PubMed ID: 29250808
[TBL] [Abstract][Full Text] [Related]
10. ESRD patients coinfected with human immunodeficiency virus and Hepatitis C: Outcomes and management challenges.
Sawinski D
Semin Dial; 2019 Mar; 32(2):159-168. PubMed ID: 30475425
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
Liu CH; Kao JH
J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
[TBL] [Abstract][Full Text] [Related]
12. Management of hepatitis C infection among patients with renal failure.
Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C infection and the patient with end-stage renal disease.
Fabrizi F; Poordad FF; Martin P
Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
[TBL] [Abstract][Full Text] [Related]
14. [Prevention and treatment of hepatitis C in patients on dialysis].
Kes P; Slavicek J
Acta Med Croatica; 2005; 59(5):483-90. PubMed ID: 16381248
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Infection in Chronic Kidney Disease.
Ladino M; Pedraza F; Roth D
J Am Soc Nephrol; 2016 Aug; 27(8):2238-46. PubMed ID: 27095799
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis C virus and chronic progressive kidney disease].
Kes P; Slavicek J
Acta Med Croatica; 2009 Dec; 63(5):431-6. PubMed ID: 20198903
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus in chronic dialysis patients.
Natov SN; Pereira BJ
Minerva Urol Nefrol; 2005 Sep; 57(3):175-97. PubMed ID: 15986016
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in dialysis patients.
Khedmat H; Amini M; Ghamar-Chehreh ME; Agah S
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):1-8. PubMed ID: 24434375
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection in dialysis patients.
Sułowicz W; Radziszewski A; Chowaniec E
Hemodial Int; 2007 Jul; 11(3):286-95. PubMed ID: 17576291
[TBL] [Abstract][Full Text] [Related]
20. Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.
Hundemer GL; Sise ME; Wisocky J; Ufere N; Friedman LS; Corey KE; Chung RT
Infect Dis (Lond); 2015; 47(12):924-9. PubMed ID: 26365684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
